omeprazole (Prilosec, Zegerid)
Title: omeprazole (Prilosec, Zegerid)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 11/6/2018 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - November 6, 2018 Category: Nutrition Source Type: news
No increased risk of lung infections among infants using popular anti-reflux medicines
(University of Otago) New University of Otago research shows infants using popular anti-reflux medicines like omeprazole are not at increased risk of pneumonia or other lower respiratory tract infections, contrary to findings from other international studies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 18, 2018 Category: International Medicine & Public Health Source Type: news
Former P & G executive named CFO of pharmaceutical firm
Former Procter& Gamble executive Tim Hendrickson has been named chief financial officer of HLS Therapeutics Inc., a specialty pharmaceutical company.
Hendrickson worked for the Cincinnati-based maker of consumer goods such as Prilosec OTC heartburn reliever (NYSE: PG) for more than 11 years, rising to finance leader in Canada for the subsidiary Procter& Gamble Pharmaceuticals Canada Inc.
He worked in finance and business development for Procter& Gamble Pharmaceuticals Canada from 2003 to 2009, … (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 11, 2018 Category: Pharmaceuticals Authors: Barrett J. Brunsman Source Type: news
P & G open to more acquisitions, CFO says
Procter& Gamble chief financial officer Jon Moeller said Thursday morning that the company is open to more acquisitions, including in the over-the-counter health care space.
Executives with the Cincinnati-based maker of consumer goods such as Prilosec OTC heartburn reliever (NYSE: PG) believe such acquisitions would pay off because of P&G ’s expertise in marketing and other areas.
“OTC healthcare (is) very attractive from a margin standpoint, from a growth standpoint, from a demographic standpoint,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 6, 2018 Category: American Health Authors: Barrett J. Brunsman Source Type: news
P & G clears hurdle to $4B acquisition
Procter& Gamble Co. today got the greenlight from the European Commission to acquire the consumer health care brands of Merck KGaA of Germany, a $4 billion deal that required a review under the European Union ’s merger regulation.
The Cincinnati-based maker of consumer goods such as Prilosec OTC heartburn reliever (NYSE: PG) intends to scale up the company’s over-the-counter health care business, which accounts for $2 billion in revenue.
“The commission concluded that the proposed transaction… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 28, 2018 Category: Biotechnology Authors: Barrett J. Brunsman Source Type: news
P & G clears hurdle to $4B acquisition
Procter& Gamble Co. today got the greenlight from the European Commission to acquire the consumer health care brands of Merck KGaA of Germany, a $4 billion deal that required a review under the European Union ’s merger regulation.
The Cincinnati-based maker of consumer goods such as Prilosec OTC heartburn reliever (NYSE: PG) intends to scale up the company’s over-the-counter health care business, which accounts for $2 billion in revenue.
“The commission concluded that the proposed transaction… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 28, 2018 Category: Pharmaceuticals Authors: Barrett J. Brunsman Source Type: news
Observation on therapeutic effect of combined acupuncture for stress gastric mucosal injury after traumatic brain injury - Sun Y, Ma T, Chen C, Zhang S.
OBJECTIVE: To observe the therapeutic effect of combined acupuncture combined with omeprazole on patients with craniocerebral trauma complicated with stress gastric mucosal injury. METHODS: Patients with stress gastric mucosal injury after cerebral... (Source: SafetyLit)
Source: SafetyLit - July 19, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Omeprazole Capsules (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - July 10, 2018 Category: Drugs & Pharmacology Source Type: news
Zydus gets USFDA nod to market drugs for stomach ailments
"Zydus Cadila has received the final approval from USFDA to market Omeprazole and Sodium bicarbonate capsules 20 mg/1100 mg (OTC)," the company said in a filing to BSE. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 17, 2018 Category: Pharmaceuticals Source Type: news
Proton Pump Inhibitors Not Tied to Hip Fractures in Alzheimer's Patients
WEDNESDAY, March 14, 2018 -- Long-term use of acid-blocking heartburn drugs, such as Nexium and Prilosec, does not increase the risk for hip fractures in people with Alzheimer ' s disease, a new study finds.
These medications belong to a class of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 14, 2018 Category: General Medicine Source Type: news
Common Heartburn Meds Show Ties to Kidney Trouble
SATURDAY, Nov. 4, 2017 -- If you ' re one of the millions of Americans who takes one of a class of anti-reflux meds such as Nexium, Prilosec and Prevacid, take heed: These drugs have been linked to higher odds of kidney trouble.
The study couldn ' t... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 4, 2017 Category: General Medicine Source Type: news
Popular Over-The-Counter Antacids Could Increase The Risk Of Stomach Cancer
This study was not able to prove that the medications lead to a higher risk of gastric cancer, it just suggested an association.
They also studied conflicts with another recent study that suggested no increased risk of stomach cancer with these medications.
That said, doctors and patients should exercise caution when using them over a long period of time.
(Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire)
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 1, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Healthwatch Local News Seen On WBZ-TV Syndicated Local Dr. Mallika Marshall Source Type: news
Acid reflux drugs could double your risk of stomach cancer
Researchers from the University of Hong Kong and University College London found that acid reflux medications, such as Prilosec, could double your risk of developing stomach cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - November 1, 2017 Category: Consumer Health News Source Type: news
Acid reflux drugs linked to increased stomach cancer risk
Conclusion
PPIs are commonly used medicines for acid reflux. This may seem like alarming news for the many people in the UK who take them, but it's important to remember that the overall risk of stomach cancer is still very low.
This study has several limitations that mean we should be cautious about the results:
This type of study can't prove PPIs caused the increased risk of cancer. The increased risk could be down to other factors.
Researchers were unable to adjust their figures to take account of some relevant confounding factors, such as alcohol and tobacco use, as these weren't routinely recorded.
Almost all the pati...
Source: NHS News Feed - November 1, 2017 Category: Consumer Health News Tags: Cancer Source Type: news
Prilosec vs. Zantac
Title: Prilosec vs. ZantacCategory: MedicationsCreated: 11/1/2017 12:00:00 AMLast Editorial Review: 11/1/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - November 1, 2017 Category: Drugs & Pharmacology Source Type: news
